Neurizons, NUZ-001 Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study 07.08.2025 - 18:08:04 Neurizon Therapeutics Limited Australia New York View original content:https://www.prnewswire.co.uk/news-releases/neurizons-nuz-001-reduces-aggregation-of-key-als-disease-target-tdp-43-in-preclinical-study-302309581.html
